|DEBIOPHARM S.A. Patent applications|
|Patent application number||Title||Published|
|20140187765||NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE - Assays for characterization of genotypic mutations of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs.||07-03-2014|
|20130012518||BICYCLIC COMPOUNDS AND THEIR USES AS DUAL C-SRC / JAK INHIBITORS - The present invention relates to substituted aromatic bicyclic compounds containing pyrimidine and pyridine rings of formula (I) having the structure as well as pharmaceutically acceptable salts thereof. The compounds of the present invention are useful as tyrosine kinase inhibitors, preferably SRC family kinases (SFKs) inhibitors, in particular as multi SFK/JAK. kinases inhibitors and even preferably as dual c-SRC/JAK kinases inhibitors, thereby inhibiting the STAT3 activation and therefore abnormal growth of particular cell types. Notably, the compounds of the present invention are useful for the treatment or inhibition of certain diseases that are the result of deregulation of STAT3.||01-10-2013|
|20090023640||Use Of A Cyclic Undecapeptide For The Preparation Of A Medicament For Administration During Myocardial Ischaemic Events - The invention relates to the use of a cyclic undecapeptide, with the structure in formula (I), for the preparation of a medicament for administration during a myocardial ischaemic event.||01-22-2009|
Patent applications by DEBIOPHARM S.A.